How the pandemic has changed our approach to stakeholder engagement

McKinsey & Company recently undertook a survey of senior executives in commercial roles within global pharma, to understand their thoughts on how the pandemic has influenced and changed the strategic and operational approach to ongoing engagement.

The report focuses on the acceleration of certain commercial-organizational trends, with building digital capabilities taking precedence. The priority was to recreate engagement virtually and without placing an additional burden on already stretched stakeholders.

There was an overwhelming view that companies would embrace agile ways of working, with raising digital capabilities, expanding field roles, increasing subject matter expert accessibility for customers, proactive marketing and new business development capabilities, seen as having high value.

In summary, the report highlights the opportunity the pandemic has presented to revisit investment in time and resources. It illustrates the importance of delivering relevant communications to HCPs, particularly given the additional pressures they are facing. Quality over quantity definitely wins.

To read the full report, visit

Related news

Copyright compliance

Managing compliance

With thousands of new regulatory guidelines issued every year, it’s easy for pharma to forget that something as simple as sharing copyright scientific content also requires a compliant approach. Keeping on top of these additional compliance requirements is a challenge, but there is a solution.

Pharma web portal

Portal pressure – making pharma portals work

According to an article in Pharmaphorum, pharma portals are underutilised by HCPs, with low engagement rates and reports of poor user experience. These portals are key to supporting the communication of product information. So given the importance of the information they provide, how can pharma make the portal experience more valuable for HCPs?


Automation is the way forward

An article in Pharmaphorum recently discussed why automating data capture is helping pharma optimise HCP engagement. A data-enriched approach enables pharma marketing teams to develop strategies which align with specific HCP preferences.

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.